Home/Filings/4/0001654954-25-005949
4//SEC Filing

Giordano Christopher Thomas 4

Accession 0001654954-25-005949

CIK 0000034956other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 6:50 PM ET

Size

11.5 KB

Accession

0001654954-25-005949

Insider Transaction Report

Form 4
Period: 2025-05-16
Transactions
  • Award

    Stock Option (right to buy)

    2025-05-16+1,400,0001,400,000 total
    Exercise: $5.89Exp: 2035-05-16Common Stock (1,400,000 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $992.00Exp: 2032-06-09Common Stock (125 underlying)
    125
  • Stock Option (right to buy)

    Exercise: $3.55Exp: 2034-05-17Common Stock (437 underlying)
    437
  • Stock Option (right to buy)

    Exercise: $5.94From: 2025-12-10Exp: 2034-12-10Common Stock (1,250,000 underlying)
    1,250,000
  • Stock Option (right to buy)

    Exercise: $3152.00Exp: 2031-07-06Common Stock (157 underlying)
    157
Footnotes (4)
  • [F1]The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on May 16, 2026, and thereafter 1/36th of the remaining shares will vest on the last day of each following month for a period of 36 months, subject to the Reporting Person's continued employment.
  • [F2]The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of July 6, 2022, July 6, 2023, July 6, 2024, and July 6, 2025, subject to the Reporting Person's continued employment.
  • [F3]The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of June 9, 2023, June 9, 2024, June 9, 2025, and June 9, 2026, subject to the Reporting Person's continued employment.
  • [F4]The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of May 17, 2025, May 17, 2026, May 17, 2027, and May 17, 2028, subject to the Reporting Person's continued employment.

Issuer

TENAX THERAPEUTICS, INC.

CIK 0000034956

Entity typeother

Related Parties

1
  • filerCIK 0001871714

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:50 PM ET
Size
11.5 KB